Viewing Study NCT06505174



Ignite Creation Date: 2024-10-26 @ 3:35 PM
Last Modification Date: 2024-10-26 @ 3:35 PM
Study NCT ID: NCT06505174
Status: COMPLETED
Last Update Posted: None
First Post: 2024-07-10

Brief Title: Effect of Treatment With Systane Ultra in Symptomatology and Visual Task Efficiency in Digital Device Users
Sponsor: None
Organization: None

Study Overview

Official Title: Effect of Treatment With Systane Ultra in Symptomatology and Visual Task Efficiency in Digital Device Users
Status: COMPLETED
Status Verified Date: 2024-07
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: No
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: This study assessed the effect of one month of use of preservative-free artificial tears Systane Ultra UD Alcon on symptomatology related to digital eye strain DES visual task performance and tear film stability in visual display terminal users
Detailed Description: Visual display terminal users 4hday with DES CVSS17 score ranged 29 to 42 and dryness OSDI score ranged 13 to 24 symptomatology were prescribed with preservative-free artificial tears Systane Ultra UD Alcon four times a day for one month collecting OSDI and CVSS17 questionnaires in four visits screening Day -7 initial Day 0 one week Day 7 and one month Day 30

Blink rate and number of eye fixations collected with eye-tracker in six simple computer tasks and out-loud reading speed were determined before and after performing all tasks on the computer Tear film stability and ocular parameters were also measured

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None